Efficacy Study of GLYC-101 to Evaluate Outcomes After Laser Ablation
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The primary objectives of this study are to evaluate safety and efficacy of topically applied
Glucoprime gel (GLYC-101, 0.1% and GLYC-101, 1.0%) in promoting wound healing in cosmetic
surgery patients undergoing Carbon Dioxide Laser Skin Resurfacing (CO2 LSR) of the lower
eyelids. The study will observe the effects of the topical agent over the course of 1 month
following the initial treatment.